Unconventional Interactions of Human Ubiquitin Conjugating Enzymes

人类泛素结合酶的非常规相互作用

基本信息

  • 批准号:
    8528627
  • 负责人:
  • 金额:
    $ 27.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-10 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

Intracellular communication via ubiquitin (Ub) signaling impacts all aspects of eukaryotic cell biology and regulates pathways critical to human development and viability. Aberrations or defects in Ub-signaling can result in numerous debilitating diseases including neurodegenerative diseases, infections, and cancer. Despite remarkable progress over the decades, we still have only a rudimentary understanding of the molecular factors and networks of interactions that govern the assembly of the proteins required for regulated Ub transfer and signaling. The ability to intervene in diseases related to Ub-signaling requires a thorough understanding of these pathways at the molecular level. The basic scheme for Ub modification involves the concerted activities and interactions of several different proteins. This proposal focuses on expanding our understanding of a central player in Ub-transfer reactions, the class of enzymes known as Ub-Conjugating Enzymes or E2s. Once thought simply to shuttle Ub to the site of modification, emerging evidence suggests that E2s can play a pivotal role in substrate recognition, determining the nature of Ub modification of a target protein, and even interacting with and influencing the activities of proteins outside the traditional Ub-transfer pathway. There are ~40 E2s in the human genome and most are thought to be directly involved in Ub transfer. Very little functional information is available for the majority of these E2s. The Research Plan outlined in this proposal seeks to substantially expand our understanding of E2 function. Using various biochemical approaches, NMR spectroscopy, crystallography, and mass spectrometry, this project seeks to develop a molecular understanding of the factors that govern 1) the intrinsic activity of E2~Ub conjugates toward particular residues, 2) E2~Ub recognition of substrates, and 3) and regulatory interactions of E2~Ub conjugates that regulate proteins outside the main Ub-transfer pathway. We have adapted and developed new tools with which to identify proteins selectively modified by particular E2~Ub conjugates. We make use of a new "in coli" expression system that can reconstruct Ub-transfer pathways in E. coli. This system allows us to generate particular E2~Ub conjugates and investigate their activity in cells without complications from competing Ub- transfer reactions. The new knowledge we seek to obtain will have a significant impact our understanding of human E2 structure and function and greatly accelerate biological research involving ubiquitylation and ubiquitin signaling.
通过泛素(Ub)信号传导的细胞内通信影响真核细胞生物学的所有方面, 调节对人类发育和生存能力至关重要的途径。Ub信号传导的异常或缺陷可以 导致许多使人衰弱的疾病,包括神经变性疾病、感染和癌症。尽管 尽管在过去的几十年里取得了巨大的进步,但我们仍然对分子因素只有初步的了解。 和相互作用的网络,控制调节Ub转移所需的蛋白质的组装, 信号干预与Ub信号相关的疾病的能力需要彻底了解 在分子水平上的这些途径。Ub修改的基本方案涉及协同活动 以及几种不同蛋白质的相互作用。这一建议的重点是扩大我们对一个 在Ub转移反应中的核心球员,被称为Ub结合酶或E2的酶类。一旦 虽然E2被认为只是将Ub运送到修改的位置,但新出现的证据表明,E2可以发挥关键作用。 在底物识别中起作用,决定靶蛋白的Ub修饰的性质,甚至相互作用 具有并影响传统Ub-转移途径外的蛋白质的活性。有~40个E2, 人类基因组和大多数被认为是直接参与Ub转移。功能非常少 对于大多数这些E2,信息是可用的。本提案中概述的研究计划旨在 大大扩展了我们对E2功能的理解。使用各种生物化学方法,NMR 光谱学,晶体学和质谱学,该项目旨在开发一种分子 理解支配1)E2-Ub缀合物对特定的细胞的固有活性的因素, 残基,2)底物的E2~Ub识别,和3)E2~Ub缀合物的调节相互作用, 调节主要Ub转移途径外的蛋白质。我们已经适应并开发了新的工具, 其用于鉴定被特定E2~Ub缀合物选择性修饰的蛋白质。我们利用一种新的“大肠杆菌” 构建了重组大肠杆菌Ub转运途径的表达系统。杆菌这个系统可以让我们产生 特别是E2-Ub缀合物,并研究它们在细胞中的活性,而不存在来自竞争性Ub- 转移反应我们寻求获得的新知识将对我们的理解产生重大影响。 人E2结构和功能以及大大加速了涉及泛素化和 泛素信号

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER S BRZOVIC其他文献

PETER S BRZOVIC的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER S BRZOVIC', 18)}}的其他基金

Defining the role of BARD1 in nucleosomal ubiquitylation
定义 BARD1 在核小体泛素化中的作用
  • 批准号:
    10368107
  • 财政年份:
    2021
  • 资助金额:
    $ 27.29万
  • 项目类别:
Defining the role of BARD1 in nucleosomal ubiquitylation
定义 BARD1 在核小体泛素化中的作用
  • 批准号:
    10610818
  • 财政年份:
    2021
  • 资助金额:
    $ 27.29万
  • 项目类别:
Defining the role of BARD1 in nucleosomal ubiquitylation
定义 BARD1 在核小体泛素化中的作用
  • 批准号:
    10231875
  • 财政年份:
    2021
  • 资助金额:
    $ 27.29万
  • 项目类别:
Unconventional Interactions of Human Ubiquitin Conjugating Enzymes
人类泛素结合酶的非常规相互作用
  • 批准号:
    8716782
  • 财政年份:
    2012
  • 资助金额:
    $ 27.29万
  • 项目类别:
Unconventional Interactions of Human Ubiquitin Conjugating Enzymes
人类泛素结合酶的非常规相互作用
  • 批准号:
    8293759
  • 财政年份:
    2012
  • 资助金额:
    $ 27.29万
  • 项目类别:
Unconventional Interactions of Human Ubiquitin Conjugating Enzymes
人类泛素结合酶的非常规相互作用
  • 批准号:
    9276349
  • 财政年份:
    2012
  • 资助金额:
    $ 27.29万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.29万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了